Barcelona, Spain

Marta Melgarejo Díaz

This inventor holds 1 USPTO granted patent. Top assignee: Landsteiner Genmed, S.l.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marta Melgarejo Díaz. Retrieved from https://idiyas.com/inventor/marta-melgarejo-díaz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marta Melgarejo Díaz: Innovator in Medical Treatments

Introduction

Marta Melgarejo Díaz is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of medical treatments through her innovative research and development. Her work focuses on addressing critical health issues associated with elevated calpain activity.

Latest Patents

Marta holds a patent for "Dipeptidyl ketoamide meta-methoxyphenyl derivatives and uses thereof." This invention relates to dipeptidyl ketoamide m-methoxyphenyl derivatives and their application in treating various diseases and conditions. These include heart injury caused by infarction, ischemia with or without reperfusion, neurodegenerative disorders, malaria, diabetic nephropathy, neurotoxicity induced by the HIV virus, cancer, and fibrotic diseases. She has 1 patent to her name.

Career Highlights

Marta is currently associated with Landsteiner Genmed, S.L., where she continues to advance her research in medical innovations. Her dedication to improving health outcomes through scientific discovery is evident in her work.

Collaborations

Marta collaborates with esteemed colleagues such as Jesús Llenas Calvo and Miriam Royo Expósito. Their combined expertise enhances the impact of their research and development efforts.

Conclusion

Marta Melgarejo Díaz exemplifies the spirit of innovation in the medical field. Her contributions through her patent and collaborations are paving the way for advancements in treatments for serious health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…